Feasibility, Yield, and Cost of Active Tuberculosis Case Finding Linked to a Mobile HIV Service in Cape Town, South Africa: A Cross-sectional Study

English version České info

Background:
The World Health Organization is currently developing guidelines on screening for tuberculosis disease to inform national screening strategies. This process is complicated by significant gaps in knowledge regarding mass screening. This study aimed to assess feasibility, uptake, yield, treatment outcomes, and costs of adding an active tuberculosis case-finding program to an existing mobile HIV testing service.

Methods and Findings:
The study was conducted at a mobile HIV testing service operating in deprived communities in Cape Town, South Africa. All HIV-negative individuals with symptoms suggestive of tuberculosis, and all HIV-positive individuals regardless of symptoms were eligible for participation and referred for sputum induction. Samples were examined by microscopy and culture. Active tuberculosis case finding was conducted on 181 days at 58 different sites. Of the 6,309 adults who accessed the mobile clinic, 1,385 were eligible and 1,130 (81.6%) were enrolled. The prevalence of smear-positive tuberculosis was 2.2% (95% CI 1.1–4.0), 3.3% (95% CI 1.4–6.4), and 0.4% (95% CI 1.4 015–6.4) in HIV-negative individuals, individuals newly diagnosed with HIV, and known HIV, respectively. The corresponding prevalence of culture-positive tuberculosis was 5.3% (95% CI 3.5–7.7), 7.4% (95% CI 4.5–11.5), 4.3% (95% CI 2.3–7.4), respectively. Of the 56 new tuberculosis cases detected, 42 started tuberculosis treatment and 34 (81.0%) completed treatment. The cost of the intervention was US$1,117 per tuberculosis case detected and US$2,458 per tuberculosis case cured. The generalisability of the study is limited to similar settings with comparable levels of deprivation and TB and HIV prevalence.

Conclusions:
Mobile active tuberculosis case finding in deprived populations with a high burden of HIV and tuberculosis is feasible, has a high uptake, yield, and treatment success. Further work is now required to examine cost-effectiveness and affordability and whether and how the same results may be achieved at scale.

Vyšlo v časopise: Feasibility, Yield, and Cost of Active Tuberculosis Case Finding Linked to a Mobile HIV Service in Cape Town, South Africa: A Cross-sectional Study. PLoS Med 9(8): e32767. doi:10.1371/journal.pmed.1001281
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1001281

Souhrn

Zdroje

1. WHO Three I's Meeting (2008) Geneva: World Health Organization. Available: http://www.who.int/hiv/pub/meetingreports/WHO_3Is_meeting_report.pdf. Accessed 31 August 2011.

2. WHO (2010) Guidelines for intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in resource-constrained settings. Geneva: World Health Organization. Available: http://www.who.int/hiv/pub/tb/9789241500708/en/index.html. Accessed 20 February 2011.

3. International Union Against Tuberculosis and Lung Disease (2007) Best practice for the care of patients with tuberculosis: a guide for low-income countries. Paris: International Union Against Tuberculosis and Lung Disease. Available: http://www.theunion.org/index.php/en/resources/scientific-publications/tuberculosis/item/104-best-practice-for-the-care-of-patients-with-tuberculosis-a-guide-for-low-income-countries. Accessed 21/9/2011.

4. International Union Against Tuberculosis and Lung Disease (2002) Interventions for TB control and elimination. Paris: International Union Against Tuberculosis and Lung Disease. Available: http://www.tbrieder.org/publications/books_english/interventions.pdf. Accessed 21/9/2011.

5. WHO (2006) Guidance for national tuberculosis programmes on the management of tuberculosis in children. Geneva: World Health Organization. Available: http://whqlibdoc.who.int/hq/2006/WHO_HTM_TB_2006.371_eng.pdf. Accessed 21/9/2011.

6. CorbettEL, BandasonT, DuongT, DauyaE, MakamureB, et al. (2010) Comparison of two active case-finding strategies for community-based diagnosis of symptomatic smear-positive tuberculosis and control of infectious tuberculosis in Harare, Zimbabwe (DETECTB): a cluster-randomised trial. Lancet 376: 1244–1253.

7. WHO (2011) Scoping meeting for the development of guidelines on screening for active TB. Geneva: World Health Organization. Available: http://www.who.int/tb/TBscreeningmeetingreport2011.pdf. Accessed 31 August 2011.

8. GolubJE, MohanCI, ComstockGW, ChaissonRE (2005) Active case finding of tuberculosis: historical perspective and future prospects. Int J Tuberc Lung Dis 9: 1183–1203.

9. KranzerK, HoubenRM, GlynnJR, BekkerLG, WoodR, et al. (2010) Yield of HIV-associated tuberculosis during intensified case finding in resource-limited settings: a systematic review and meta-analysis. Lancet Infect Dis 10: 93–102.

10. Van SchaikN, KranzerK, WoodR, BekkerLG (2010) Earlier HIV diagnosis - are mobile services the answer? S Afr Med J 100: 671–674.

11. Western Cape Department of Health.The Western Cape Antiretroviral Programme (2006) Cape Town: Provincial Government of the Western Cape: Western Cape Department of Health. Available: http://web.uct.ac.za/depts/epi/artrollout/. Accessed 2 February 2011.

12. WHO (2000) Costing guidelines for HIV/AIDS prevention strategies. UNAIDS Best Practice Collection - Key Materials. Geneva: UNAIDS. Available: http://www.unaids.org/html/pub/publications/irc-pub05/jc412-costguidel_en_pdf.pdf. Accessed 14 September 2011.

13. DrummondMF, O'BrienB, StoddartGL (1997) Methods for the economic evaluation of health care programmes. New York: Oxford University Press.

14. KumaranayakeL (2000) The real and the nominal? Making inflationary adjustments to cost and other economic data. Health Policy Plan 15: 230–234.

15. International Monentary Fund. Available: http://www.imf.org. Accessed 15 Augut 2011.

16. SinanovicE, FloydK, DudleyL, AzevedoV, GrantR, et al. (2003) Cost and cost-effectiveness of community-based care for tuberculosis in Cape Town, South Africa. Int J Tuberc Lung Dis 7: S56–62.

17. University of the Witswatersrand and Centre for Global Health and Development, Boston University (20110 The cost of the Xpert diagnostic algorithm for TB. Results of the national TB cost model (NTCM) 2011/12 to 2016/17. Witswatersrand and Boston: University of the Witswatersrand and Centre for Global Health and Development, Boston University.

18. Final evaluation report enhanced tuberculosis adherence programm. Cape Town. Available: http://www.mrc.ac.za/healthsystems/finalr.pdf. Accessed 1 September 2011.

19. StorlaDG, YimerS, BjuneGA (2008) A systematic review of delay in the diagnosis and treatment of tuberculosis. BMC Public Health 8: 15.

20. MunseriPJ, BakariM, PallangyoK, SandstromE (2010) Tuberculosis in HIV voluntary counselling and testing centres in Dar es Salaam, Tanzania. Scand J Infect Dis 42: 767–774.

21. LawnSD, EdwardsDJ, KranzerK, VogtM, BekkerLG, et al. (2009) Urine lipoarabinomannan assay for tuberculosis screening before antiretroviral therapy diagnostic yield and association with immune reconstitution disease. AIDS 23: 1875–1880.

22. LawnSD, BrooksSV, KranzerK, NicolMP, WhitelawA, et al. (2011) Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIf assay: a prospective study. PLoS Med 8: e1001067 doi:10.1371/journal.pmed.1001067.

23. BassettIV, WangB, ChettyS, GiddyJ, LosinaE, et al. (2010) Intensive tuberculosis screening for HIV-infected patients starting antiretroviral therapy in Durban, South Africa. Clin Infect Dis 51: 823–829.

24. CasselsA, HeinemanE, LeClerqS, GurungPK, RahutCB (1982) Tuberculosis case-finding in Eastern Nepal. Tubercle 63: 175–185.

25. den BoonS, VerverS, LombardCJ, BatemanED, IrusenEM, et al. (2008) Comparison of symptoms and treatment outcomes between actively and passively detected tuberculosis cases: the additional value of active case finding. Epidemiol Infect 136: 1342–1349.

26. SanthaT, RenuG, FriedenTR, SubramaniR, GopiPG, et al. (2003) Are community surveys to detect tuberculosis in high prevalence areas useful? Results of a comparative study from Tiruvallur District, South India. Int J Tuberc Lung Dis 7: 258–265.

27. GuptaA, NayakU, RamM, BhosaleR, PatilS, et al. (2007) Postpartum tuberculosis incidence and mortality among HIV-infected women and their infants in Pune, India, 2002–2005. Clin Infect Dis 45: 241–249.

28. HarperI, FryattR, WhiteA (1996) Tuberculosis case finding in remote mountainous areas–are microscopy camps of any value? Experience from Nepal. Tuber Lung Dis 77: 384–388.

29. BothaE, den BoonS, LawrenceKA, ReuterH, VerverS, et al. (2008) From suspect to patient: tuberculosis diagnosis and treatment initiation in health facilities in South Africa. Int J Tuberc Lung Dis 12: 936–941.

30. BothaE, Den BoonS, VerverS, DunbarR, LawrenceKA, et al. (2008) Initial default from tuberculosis treatment: how often does it happen and what are the reasons? Int J Tuberc Lung Dis 12: 820–823.

31. EdgintonME, WongML, PhofaR, MahlabaD, HodkinsonHJ (2005) Tuberculosis at Chris Hani Baragwanath Hospital: numbers of patients diagnosed and outcomes of referrals to district clinics. Int J Tuberc Lung Dis 9: 398–402.

32. DunbarR, LawrenceK, VerverS, EnarsonDA, LombardC, et al. (2011) Accuracy and completeness of recording of confirmed tuberculosis in two South African communities. Int J Tuberc Lung Dis 15: 337–343.

33. BoehmeCC, NicolMP, NabetaP, MichaelJS, GotuzzoE, et al. (2011) Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. Lancet 377: 1495–1505.

34. ThorntonR (2005) The impact of incentives on learning HIV status: evidence from a field experiment. Cambridge (Massachusetts): Havard University.

35. HauslerHP, SinanovicE, KumaranayakeL, NaidooP, SchoemanH, et al. (2006) Costs of measures to control tuberculosis/HIV in public primary care facilities in Cape Town, South Africa. Bull World Health Organ 84: 528–536.

36. SuttonBS, AriasMS, ChhengP, EangMT, KimerlingME (2009) The cost of intensified case finding and isoniazid preventive therapy for HIV-infected patients in Battambang, Cambodia. Int J Tuberc Lung Dis 13: 713–718.

37. DowdyDW, O'BrienMA, BishaiD (2008) Cost-effectiveness of novel diagnostic tools for the diagnosis of tuberculosis. Int J Tuberc Lung Dis 12: 1021–1029.

38. ShillcuttSD, WalkerDG, GoodmanCA, MillsAJ (2009) Cost effectiveness in low- and middle-income countries: a review of the debates surrounding decision rules. Pharmacoeconomics 27: 903–917.

39. World Bank (2012) GDP per capita (current US$). Available: http://data.worldbank.org/indicator/NY.GDP.PCAP.CD. Accessed 2 May 2012.

40. AylesH, SchaapA, NotaA, SismanidisC, TembweR, et al. (2009) Prevalence of tuberculosis, HIV and respiratory symptoms in two Zambian communities: implications for tuberculosis control in the era of HIV. PLoS One 4: e5602 doi:10.1371/journal.pone.0005602.

41. MiddelkoopK, BekkerLG, MyerL, WhitelawA, GrantA, et al. (2010) Antiretroviral program associated with reduction in untreated prevalent tuberculosis in a South African township. Am J Respir Crit Care Med 182: 1080–1085.

42. CorbettEL, BandasonT, CheungYB, MakamureB, DauyaE, et al. (2009) Prevalent infectious tuberculosis in Harare, Zimbabwe: burden, risk factors and implications for control. Int J Tuberc Lung Dis 13: 1231–1237.

43. WoodR, MiddelkoopK, MyerL, GrantAD, WhitelawA, et al. (2007) Undiagnosed tuberculosis in a community with high HIV prevalence: implications for tuberculosis control. Am J Respir Crit Care Med 175: 87–93.

44. DemissieM, ZenebereB, BerhaneY, LindtjornB (2002) A rapid survey to determine the prevalence of smear-positive tuberculosis in Addis Ababa. Int J Tuberc Lung Dis 6: 580–584.

45. SekandiJN, NeuhauserD, SmythK, WhalenCC (2009) Active case finding of undetected tuberculosis among chronic coughers in a slum setting in Kampala, Uganda. Int J Tuberc Lung Dis 13: 508–513.

46. GuwatuddeD, ZalwangoS, KamyaMR, DebanneSM, DiazMI, et al. (2003) Burden of tuberculosis in Kampala, Uganda. Bull World Health Organ 81: 799–805.

47. den BoonS, van LillSW, BorgdorffMW, EnarsonDA, VerverS, et al. (2007) High prevalence of tuberculosis in previously treated patients, Cape Town, South Africa. Emerg Infect Dis 13: 1189–1194.

48. PronykPM, JoshiB, HargreavesJR, MadonselaT, CollinsonMA, et al. (2001) Active case finding: understanding the burden of tuberculosis in rural South Africa. Int J Tuberc Lung Dis 5: 611–618.

49. KranzerK, OlsonL, van SchaikN, RaditlhaloE, HudsonE, et al. (2011) Quality of induced sputum using a human-powered nebuliser in a mobile human immunodeficiency virus testing service in South Africa. Int J Tuberc Lung Dis 15: 1077–1081.

50. WHO (2011) Global tuberculosis control. Geneva: World Health Organization. Available: http://whqlibdoc.who.int/publications/2011/9789241564380_eng.pdf.

51. HarriesAD, ZachariahR, CorbettEL, LawnSD, Santos-FilhoET, et al. (2010) The HIV-associated tuberculosis epidemic–when will we act? Lancet 375: 1906–1919.

52. van't HoogAH, LasersonKF, GithuiWA, MemeHK, AgayaJA, et al. (2011) High prevalence of pulmonary tuberculosis and inadequate case finding in rural western Kenya. Am J Respir Crit Care Med 183: 1245–1253.